DoD Rare Cancers, Concept Award

The FY25 Rare Cancers Research Program Concept Award provides funding for innovative research focused on rare cancers, defined as those affecting six or fewer individuals per 100,000 annually in the U.S. The U.S. Army Medical Research Acquisition Activity (USAMRAA) administers this program. Proposed studies should be groundbreaking, untested, and relevant for active-duty service members, veterans, military beneficiaries, and the general public. The total funding available is approximately $2.38 million, with a cap of $140,000 per application and a maximum performance period of two years. The submission process involves a two-step application: first, a Letter of Intent due by July 22, 2025, and then a full application by August 26, 2025. Eligibility extends to various organizations and institutions, including non-profit, for-profit, domestic, and foreign entities, provided that their principal investigators meet specific criteria. Funds cannot be used for clinical trials or travel beyond specified limits. Passing both peer and programmatic review processes is necessary for securing funding, ensuring that proposals align with the program’s mission to advance rare cancer research. Overall, this award aims to inspire high-risk, high-reward research initiatives in the field of rare cancers.